You are viewing: China Remote Patient Monitoring (RPM) Market analysis

The China Remote Patient Monitoring (RPM) Market was valued at $2412 Million in 2026 and projected to reach to $5294.2 Million by 2031, representing a compound annual growth rate of 17.0%. China's Remote Patient Monitoring market is positioned for exceptional growth through 2031, driven by structural demographic shifts and strategic healthcare modernization.

China Remote Patient Monitoring (RPM) Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Remote Patient Monitoring (RPM) Market Trends and Insights

  • This represents a compound annual growth rate of 17.0%, significantly outpacing global trends.
  • China's aging population, rising prevalence of chronic diseases, and government initiatives to digitalize healthcare delivery are driving rapid adoption of RPM solutions across urban and rural regions. The Chinese market benefits from strong technological infrastructure, increasing smartphone penetration, and supportive regulatory frameworks that encourage remote healthcare innovation.
  • China's healthcare system is actively integrating RPM technologies to reduce hospital burden and improve patient outcomes in cardiovascular, respiratory, and metabolic disease management.
  • Between 2026 and 2031, China is expected to consolidate its position as a leading RPM market in Asia Pacific, with investments from both domestic and international players accelerating market penetration. Key growth catalysts in China include government reimbursement policies, expansion of 5G networks enabling real-time patient data transmission, and rising consumer awareness of preventive healthcare.
  • China's RPM market reflects the nation's broader digital health transformation and commitment to accessible, technology-enabled patient care..

Key Market Statistics

  • CAGR (2026-2031) 17.0% CAGR
  • Market Size, 2026 ~USD 2412 Million
  • Forecast, 2031 ~USD 5294.2 Million
  • Country China

China Remote Patient Monitoring (RPM) Market Overview

Rapid Market Expansion :

China's RPM market is projected to grow from USD 2,412.0 million in 2026 to USD 5,294.2 million by 2031, representing a 17.0% CAGR—significantly exceeding the global growth rate of 12.8%.

Aging Population Driver :

China's rapidly aging demographic, with over 280 million citizens aged 60+, is creating unprecedented demand for remote monitoring solutions to manage chronic diseases and reduce healthcare burden.

Government Digital Health Initiatives :

National policies promoting healthcare digitalization and telemedicine integration are accelerating RPM adoption across urban and rural regions, supported by substantial government investment.

Chronic Disease Prevalence :

Rising incidence of diabetes, hypertension, and cardiovascular diseases among China's population is driving healthcare providers to adopt remote monitoring technologies for continuous patient management.

China Remote Patient Monitoring (RPM) Market Dynamics

  • The government's commitment to digital health infrastructure, combined with increasing smartphone penetration and 5G deployment, creates an ideal environment for RPM technology adoption.
  • Healthcare providers are increasingly investing in remote monitoring capabilities to address the strain of chronic disease management across a population exceeding 1.4 billion. The market will be shaped by regulatory frameworks supporting telemedicine, integration with existing healthcare systems, and growing consumer acceptance of digital health solutions.
  • Key opportunities exist in rural healthcare delivery, elderly care management, and chronic disease monitoring.
  • Competition will intensify as both domestic and international players expand their presence, driving innovation and affordability in RPM solutions tailored to China's unique healthcare landscape..

Related Ecosystem

Cardiovascular Devices

Top Technologies
    Top Companies

      Diagnostic Imaging

      Top Technologies
        Top Companies

          Healthcare It

          Top Technologies
            Top Companies

              Key Takeaways

              • China's RPM market is projected to grow from USD 2,412.0 million in 2026 to USD 5,294.2 million by 2031, representing a 17.0% CAGR.
              • China's aging demographic and high burden of chronic diseases are primary drivers accelerating RPM adoption across the country.
              • Government digital health initiatives and 5G infrastructure expansion in China are enabling seamless remote patient monitoring deployment.
              • China is positioned as the fastest-growing RPM market in Asia Pacific, attracting significant investment from domestic and international healthcare technology providers.

              Remote Patient Monitoring (RPM) Market Report Scope

              Report Metric Details
              Base Year 2026
              Fastest Growing Segment SYNCHRONOUS (Transmission Type)
              Forecast Period 2026–2031
              Growth Rate CAGR of 12.8% from 2026 to 2031
              Largest Segment HEALTHCARE PROVIDERS (End User)
              Market Size Base Year (Billions) ~USD 36.32 (2026)
              Revenue Forecast (Billions) ~USD 66.33 (2031)
              Segments Covered Component, Function, Type, Deployment Model, Transmission Type, Indication, End User, Deployment Type

              China Remote Patient Monitoring (RPM) Market Report Segmentation

              8 segment dimensions are covered across the global market.

              By Component

              • Devices
              • Services
              • Software

              By Function

              • Blood Glucose Monitoring
              • Cardiac Monitoring
              • Fetal & Neonatal Monitoring
              • Multiparameter Monitoring
              • Neurological Monitoring
              • Other Monitoring Devices
              • Pulse Oximeters
              • Respiratory Monitoring
              • Thermometers
              • Weight Monitoring

              By Type

              • Ambulatory Surgical Centers, Ambulatory Care Centers, And Other Outpatient Settings
              • Handheld & Portable
              • Handheld & Portable Devices
              • Home Healthcare
              • Hospitals
              • Implantable
              • Implantable Devices
              • Long-Term Care & Assisted Living Facilities
              • Other Healthcare Providers
              • Others (Stationary Devices And Others)
              • Others (Stationary Devices, And Others)
              • Wearable
              • Wearable Devices

              By Deployment Model

              • Cloud-Based Model
              • On-Premise Model

              By Transmission Type

              • Asynchronous
              • Synchronous

              By Indication

              • Cardiology
              • Diabetes
              • Mental Health
              • Neurology
              • Oncology
              • Other Indications
              • Respiratory Disorders
              • Sleep Disorders
              • Wellness Improvement

              By End User

              • Healthcare Payers
              • Healthcare Providers
              • Medtech Companies
              • Other End Users
              • Patients
              • Pharmaceutical & Biotechnology Companies

              By Deployment Type

              • Cloud-Based
              • On-Premises

              CHINA: REMOTE PATIENT MONITORING MARKET, BY END USER, 2024–2031

              Segment20242025202620272028202920302031CAGR (%)
              HEALTHCARE PAYERS284.6339.4402.5475.2559.1655.6765.9892.317.3
              HEALTHCARE PROVIDERS848.91009.41193.514051648.11926.52243.92606.616.9
              MEDTECH COMPANIES88.9105.2123.7144.9169.1196.7228263.516.3
              OTHER END USERS51.861.873.486.7102119.6139.7162.717.3
              PATIENTS283.7339.4403.7478.1564.1663.4777.3908.417.6
              PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES154.3182.7215.2252.3294.8343.2398.1460.616.4
              TOTAL1712.12037.924122842.23337.439054552.95294.217

              Target Audience

              • Healthcare Technology Investors : Investors seeking high-growth opportunities in Asia need China RPM market data to evaluate investment potential, assess competitive landscape, and identify acquisition or partnership targets in this 17% CAGR market.
              • Medical Device & Software Manufacturers : Companies developing RPM solutions require China-specific market intelligence to guide product development, localization strategies, regulatory compliance, and market entry planning for this rapidly expanding segment.
              • Healthcare Providers & Hospital Networks : Chinese hospitals and healthcare systems need market insights to benchmark RPM adoption rates, evaluate vendor solutions, understand reimbursement models, and plan digital transformation initiatives.
              • Government & Policy Makers : Chinese health authorities and policymakers require market data to assess telemedicine infrastructure needs, evaluate policy effectiveness, and allocate resources for digital health initiatives supporting aging populations.
              • Management Consultants & Strategy Firms : Consulting firms advising healthcare clients in China need validated market data, growth forecasts, and trend analysis to develop credible strategic recommendations and competitive positioning strategies.

              Key Companies in the China Remote Patient Monitoring (RPM) Market

              CompanyHQOwnershipStrongest segments
              KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep and Respiratory Care),Personal Health,
              MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes and Monitoring),
              GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
              ABBOTTUnited StatesPublic CompanyDiagnostic Products,Medical Devices,Nutritional Products,
              ORACLEUnited StatesPublic CompanyCloud Applications (Fusion ERP/EPM/SCM/HCM, NetSuite, CX, Health),Database and Infrastructure Technologies (Oracle DB, MySQL, Autonomous, Middleware, Java),Cloud Infrastructure (Compute, Storage, Networking, AI/ML, Digital Assistant, Blockchain),
              BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, LAAC, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
              NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors and clinical information systems,Physiological measuring equipment (EEG, ECG, EMG, polygraphs),Defibrillators, AEDs, and resuscitation devices,
              SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
              BAXTERUnited StatesPublic CompanyMedical Products & Therapies (IV solutions, infusion, parenteral nutrition, renal and related therapies),Healthcare Systems & Technologies (smart beds, monitoring, OR integration, surgical equipment, respiratory devices),Pharmaceuticals (generic and specialty injectables, inhaled anesthetics, compounding services),

              KONINKLIJKE PHILIPS N.V.

              Koninklijke Philips N.V. is a Dutch multinational public company founded in 1891 with 64,317 employees, operating across healthcare and technology sectors.

              MEDTRONIC

              Medtronic is a public medical technology company founded in 1949 in Ireland with 95,000 employees, providing medical devices and healthcare solutions.

              GE HEALTHCARE

              GE Healthcare is a public healthcare company established in 2022 in the United States with 54,000 employees, offering medical imaging and healthcare technology.

              ABBOTT

              Abbott is a public healthcare and diagnostics company founded in 1888 in the United States with 115,000 employees.

              ORACLE

              Oracle is a public software and cloud computing company founded in 1977 in the United States with 141,000 employees.

              BOSTON SCIENTIFIC CORPORATION

              Boston Scientific Corporation is a public medical device company founded in 1979 in the United States with 59,000 employees.

              NIHON KOHDEN CORPORATION

              Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, specializing in medical equipment and healthcare technology.

              SIEMENS HEALTHINEERS AG

              Siemens Healthineers AG is a German public healthcare company founded in 1896 with 72,369 employees, providing medical imaging and diagnostic solutions.

              BAXTER

              Baxter is a public healthcare company founded in 1931 in the United States with 37,500 employees, specializing in medical devices and pharmaceuticals.

              Reasons to Buy this Report

              • Market Size & Growth Validation : Obtain precise market valuation for China (USD 2,412M in 2026) and verified 5-year forecast (USD 5,294.2M by 2031) to support investment decisions and business planning in this high-growth market.
              • Competitive Intelligence : Understand China-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies in the world's second-largest economy.
              • Regulatory & Policy Insights : Access detailed analysis of Chinese government digital health initiatives, telemedicine regulations, and healthcare digitalization policies that directly impact RPM market development and compliance requirements.
              • Demographic & Clinical Opportunity Assessment : Leverage data on China's aging population, chronic disease prevalence, and healthcare infrastructure gaps to identify high-potential patient segments and geographic markets for RPM solutions.
              • Strategic Growth Planning : Use China-specific market forecasts and trend analysis to develop targeted go-to-market strategies, product localization plans, and revenue projections for RPM business expansion in Asia's largest market.

              Frequently asked questions

              What is the current market size of Remote Patient Monitoring in China?

              China's RPM market was valued at USD 2,412.0 million in 2026 and is expected to grow to USD 5,294.2 million by 2031.

              What is the projected growth rate for China's RPM market?

              China's RPM market is projected to grow at a compound annual growth rate (CAGR) of 17.0% from 2026 to 2031.

              What are the main drivers of RPM adoption in China?

              Key drivers include China's aging population, rising chronic disease prevalence, government digital health initiatives, 5G network expansion, and increasing consumer awareness of preventive healthcare.

              How does China's RPM market growth compare to global trends?

              China's 17.0% CAGR significantly exceeds the global RPM market CAGR of 12.8%, positioning China as a high-growth market within the Asia Pacific region.

              Which disease areas are driving RPM demand in China?

              Cardiovascular disease, respiratory conditions, and metabolic disorders are primary disease areas driving RPM adoption and investment in China's healthcare system.

              RESEARCH METHODOLOGY

              The study involved major activities in estimating the current market size for the remote patient monitoring market.

              Exhaustive secondary research was done to collect information on the remote patient monitoring industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the remote patient monitoring market.  

              Secondary Research

              In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to in order to identify and collect information for the study of the remote patient monitoring market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

              Primary Research

              Extensive primary research was conducted after acquiring basic knowledge about the global remote patient monitoring market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (Hospital directors, Hospital Vice Presidents, Department heads, and Critical care specialists ) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions—North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

              BREAKDOWN OF PRIMARY INTERVIEW PARTICIPANTS

              Remote Patient Monitoring Market 
 Size, and Share

              Note 1: Others include sales managers, marketing managers, and product managers.

              Note 2: Tiers of companies are defined on the basis of their total revenues in 2025. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

              To know about the assumptions considered for the study, download the pdf brochure

              Market Size Estimation

              Both top-down and bottom-up approaches were used to estimate and validate the total size of the remote patient monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

               The research methodology used to estimate the market size includes the following:

              Remote Patient Monitoring Market Top Down and Bottom Up Approach

              Data Triangulation

              After arriving at the overall market size—using the market size estimation processes—the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the remote patient monitoring market.

              Market Definition

              The remote patient monitoring (RPM) market involves the use of technology to remotely monitor and manage patients' health conditions outside of traditional healthcare settings, as well as in patient settings. It leverages devices such as wearables, sensors, and mobile applications to track vital signs and chronic diseases. RPM allows healthcare providers to access real-time data for better decision-making and personalized care.

              Key Stakeholders

              • RPM Equipment and devices Manufacturers
              • Suppliers and Distributors of RPM Equipment
              • RPM software provider
              • Healthcare IT Service Providers
              • Healthcare Insurance Companies/Payers
              • Healthcare Institutions/Providers (Hospitals, Clinics, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
              • Venture Capitalists
              • Government Bodies/Regulatory Bodies
              • Corporate Entities
              • Accountable Care Organizations
              • RPM Resource Centers
              • Research and Consulting Firms
              • Medical Research Institutes
              • Clinical Departments

              Report Objectives

              • To define, describe, and forecast the global remote patient monitoring market based on component, indication, end user, and region.
              • To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing the market growth
              • To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall remote patient monitoring market
              • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
              • To strategically analyze the market structure profile of the key players of the remote patient monitoring market and comprehensively analyze their core competencies.
              • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
              • To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, funding, grants, agreements, sales contracts, product testing, FDA approval, product approval, and alliances in the remote patient monitoring market during the forecast period.

              Available customizations:

              With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

              • Product Analysis: Product matrix, which gives a detailed comparison of the product portfolios of each company.
              • Geographic Analysis:  Further breakdown of Latin American remote patient monitoring into specific countries, the Middle East, and Africa remote patient monitoring into specific countries, and further breakdown of European remote patient monitoring into specific countries

               

              Get the Full Remote Patient Monitoring (RPM) Market Report

              Full forecast, segment splits, and company analysis for all Remote Patient Monitoring (RPM) Market.

              Need a Tailored Report?

              Customize this report to your needs

              Get 10% FREE Customization

              Customize This Report
              Fact checked
              DMCA.com Protection Status